Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Citigroup (C) Stock Nears New 52‑Week High as Restructuring Deepens – Latest News, Outlook and 2025–2030 Forecasts

Citigroup (C) Stock Nears New 52‑Week High as Restructuring Deepens – Latest News, Outlook and 2025–2030 Forecasts

Citigroup Inc. continues to be one of 2025’s standout large‑cap bank stocks. On Thursday, the shares traded around $108.41, up about 1.6% on the day and hitting an intraday high near $108.70, extending a rally that has already lifted the stock more than 50% year‑to‑date and pushed it beyond its recent 52‑week highs. Reuters+1
Qualcomm (QCOM) Stock on December 4, 2025: AI Momentum, Dividend Record Date and 2026 Forecasts

Qualcomm (QCOM) Stock on December 4, 2025: AI Momentum, Dividend Record Date and 2026 Forecasts

Qualcomm is back in the spotlight as 2025 winds down. As of the afternoon of December 4, 2025, the stock is trading around $174–175 per share, giving the company a market value of roughly $187 billion.MarketBeat Year‑to‑date total return sits in the mid‑teens, slightly ahead of the broader market but far below the explosive gains seen in some headline AI names.Total Real Returns+1
Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce, Inc. stock is trading just below its agreed $70 per‑share cash buyout price from private‑equity firm Thoma Bravo, leaving a narrow merger‑arbitrage spread while investors weigh solid recurring‑revenue growth, mixed earnings, and a broadly “Hold” view from Wall Street analysts as of December 4, 2025. GlobeNewswire+1
D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

As of the afternoon on December 4, 2025, D‑Wave Quantum Inc. is trading around $28.37, up roughly 13% on the day, after hitting an intraday high of about $28.52 on heavy volume of more than 31 million shares. Over the last year, the stock has swung between $2.88 and $46.75, underscoring just how volatile this quantum computing pure‑play has become. MarketBeat
4 December 2025
McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s Corporation heads into the final stretch of 2025 as one of the market’s core defensive consumer names, but the story is no longer just about burgers and fries. Investors are weighing a fresh dividend hike, aggressive price cuts to win back budget‑strained diners, surging digital engagement, and a crowded field of analyst forecasts that mostly point to moderate upside rather than a moonshot.
Rocket Lab (RKLB) Stock Soars on Record Launches and JAXA Deal Despite Neutron Delay – December 2025 Outlook

Rocket Lab (RKLB) Stock Soars on Record Launches and JAXA Deal Despite Neutron Delay – December 2025 Outlook

Rocket Lab Corporation’s stock is back in rally mode in early December 2025. After a sharp pullback in November tied to delays in its next‑generation Neutron rocket, shares are climbing again on the back of record launch activity, new Japanese contracts, and a wave of fresh analyst upgrades and commentary. Via Satellite+2Quiver Quantitative+2
4 December 2025
Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

Kroger Co. shares dropped roughly 4–5% on Thursday after the supermarket giant reported third‑quarter 2025 results that featured a sizable $2.6 billion impairment charge, a slight sales miss and a narrowed full‑year sales outlook — even as profits and margins came in strong and guidance for earnings per share was nudged higher. Kroger Investor Relations+2Reuters+2
Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Amgen Inc. has quietly turned into one of 2025’s standout large‑cap healthcare winners. The biotech heavyweight is trading just below fresh 52‑week highs, powered by a clean sweep of earnings beats, a deepening obesity‑drug story around its MariTide program, and full FDA approval for its lung‑cancer therapy Imdelltra. At the same time, investors are grappling with tax and patent overhangs, looming drug price pressure and an increasingly crowded obesity market.
1 839 840 841 842 843 890
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.